A study published in the Journal of the American Medical Association Surgery is the first in North America to demonstrate that living-donor liver transplant is a viable option for patients who have systemically controlled colorectal cancer and liver tumours that cannot be surgically removed.
“This study will help take what is now purely research into standard of care,” senior author, Toronto faculty, Dr. Gonzalo Sapisochin (front L) assisted by Toronto fellow Dr. David Henault, (back R). Photo: UHN
Read more here: https://www.uhn.ca/corporate/News/Pages/Living_donation_opens_new_doors_for_colorectal_cancer_patients.aspx